000 01503 a2200457 4500
005 20250516180421.0
264 0 _c20140812
008 201408s 0 0 eng d
022 _a1976-670X
024 7 _a10.5483/bmbrep.2013.46.12.106
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKim, Yong-Mo
245 0 0 _aNovel AGLP-1 albumin fusion protein as a long-lasting agent for type 2 diabetes.
_h[electronic resource]
260 _bBMB reports
_cDec 2013
300 _a606-10 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAlanine
_xgenetics
650 0 4 _aAnimals
650 0 4 _aBlood Glucose
_xanalysis
650 0 4 _aCHO Cells
650 0 4 _aCell Line, Tumor
650 0 4 _aCricetinae
650 0 4 _aCricetulus
650 0 4 _aDiabetes Mellitus, Type 2
_xmetabolism
650 0 4 _aDipeptidyl Peptidase 4
_xmetabolism
650 0 4 _aGlucagon-Like Peptide 1
_xgenetics
650 0 4 _aGlucose Tolerance Test
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xmetabolism
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aRats
650 0 4 _aRecombinant Fusion Proteins
_xbiosynthesis
650 0 4 _aSerum Albumin
_xgenetics
650 0 4 _aTransfection
700 1 _aLee, Sang Mee
700 1 _aChung, Hye-Shin
773 0 _tBMB reports
_gvol. 46
_gno. 12
_gp. 606-10
856 4 0 _uhttps://doi.org/10.5483/bmbrep.2013.46.12.106
_zAvailable from publisher's website
999 _c23234939
_d23234939